Human Genome Sciences Inc. v Eli Lilly and Company
Enlazado como:
Extracto
Human Genome Sciences Inc. v Eli Lilly and Company
No longer available (Autolink)
Ver el contenido completo de este documento
Afectaciones
REFIERE
- Smithkline Beecham Plc v Apotex Europe Ltd (Costs) (No.2)
- Kirin-Amgen Inc. and Others v Transkaryotic Therapies Inc. and Others and other appeals
- Asahi Medical Company Ltd v Macopharma (UK) Ltd
[ver más]
SIGUE
APLICA
CITA
- Kirin-Amgen v Hoechst Marion Roussel Ltd
- Synthon BV v Smithkline Beecham Plc (No.2)
- Merrell Dow Pharmaceuticals Inc. and Others v H.N. Norton & Company Ltd ; Merrell Dow Pharmaceuticals Inc. and Others v Penn Pharmaceuticals Ltd and Others
[ver más]
CONSIDERA
- Patents Act 1977 - Artículos : S-1
- Patents Act 1977 - Artículos : S-3
- Patents Act 1977 - Artículos : S-72
[ver más]
CITADA NEUTRALMENTE por
- Coloplast A/S v MacGregor Healthcare Ltd
- Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd
- Idenix Pharmaceuticals, Inc. v Gilead Sciences, Inc. and Others
[ver más]
CONSIDERADA por
- Glenmark Generics (Europe) Ltd Generics [UK] Ltd (T/A Mylan) v The Wellcome Foundation Ltd Glaxo Group Ltd (Defendants/Part 20 Claimants)
- Ratiopharm (UK) Ltd v Alza Corporation and Janssen-Cilag Ltd and another
- Adolf Nissen Elektrobau GmbH & Company KG v Horizont Group GmbH
[ver más]
APLICADA por
RECURSO RESUELTO por
REFERIDA por
- Safestand Ltd v Weston Homes Plc
- Illumina, Inc. and Others (Claimants to case no HC-2015-001175) Illumina, Inc. and Another (Claimants in case no HP-2015-000047) v Premaitha Health Plc and Another (Defendants in case nos HC-2015-001175 HP-2015-000047)
- Akebia Therapeutics Inc. v Fibrogen, Inc.
[ver más]
REPORTED OPINION OF por